M Michelle Berrey's Net Worth
$614 Thousand
Who is M Michelle Berrey?
M Michelle Berrey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., CHIMERIX INC, Ocean Biomedical, Inc., and Pharmasset Inc.
SEC CIK
M Michelle Berrey's CIK is 0001397329
Past Insider Trading and Trends
2014 was M Michelle Berrey's most active year for acquiring shares with 7 total transactions. M Michelle Berrey's most active month to acquire stocks was the month of December. 2023 was M Michelle Berrey's most active year for disposing of shares, totalling 8 transactions. M Michelle Berrey's most active month to dispose stocks was the month of October. 2014 saw M Michelle Berrey paying a total of $481,215.42 for 287,177 shares, this is the most they've acquired in one year. In 2023 M Michelle Berrey cashed out on 218,477 shares for a total of $1,571,733.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
President, R&D and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -80.14K |
$19.00 | -$1,522,641.00 |
0
|
Nov 8
| |||
Form 4
| -1.53% | -1.25K |
$11.57 | -$14,416.22 | 80.14K |
Sep 14
| |||
Form 4
| -1.51% | -1.25K |
$12.04 | -$15,001.84 | 81.39K |
Jun 14
| |||
Form 4
| -1.49% | -1.25K |
$15.79 | -$19,674.34 | 82.63K |
Mar 14
| |||
Form 4
| +21.25% | 14.7K |
—
|
—
| 83.88K |
Jan 27
| |||
Form 4
| -1.09% | -765.00 |
$12.37 | -$9,463.05 | 69.18K |
Dec 31
| |||
Form 4
| -1.75% | -1.25K |
$14.94 | -$18,615.24 | 69.94K |
Dec 14
| |||
Form 4
| -1.72% | -1.25K |
$17.14 | -$21,356.44 | 71.19K |
Sep 14
| |||
Form 4
| -6.44% | -4.98K |
$12.10 | -$60,306.40 | 72.43K |
Jun 14
| |||
Form 4
| +15.35% | 10.3K |
—
|
—
| 77.42K |
Jan 27
| |||
Form 4
|
∞
| 67.12K |
—
|
—
| 67.12K |
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.913275
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +11.15% | 10K |
$4.50 | $45,015.00 | 99.69K |
Jun 12
| |||
Form 4
| +3.58% | 11.25K |
$4.26 | $47,925.00 | 325.26K |
May 8
| |||
Form 4
| +3.34% | 10.07K |
$4.26 | $42,902.46 | 311.34K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +7.81% | 23.47K |
$4.26 | $99,999.24 | 323.95K |
Jun 21
| |||
Form 4
| +1.25% | 4.52K |
$4.10 | $18,530.73 | 366.68K |
Mar 10
| |||
Form 4
| +25.68% | 74K |
—
|
—
| 362.16K |
Jan 24
| |||
Form 4
| +0.84% | 2.4K |
$4.26 | $10,224.00 | 288.16K |
Nov 29
| |||
Form 4
| +1.61% | 4.52K |
$4.05 | $18,318.15 | 285.76K |
Sep 9
| |||
Form 4
| +8.66% | 22.42K |
$4.47 | $100,226.41 | 281.24K |
Aug 29
| |||
Form 4
| +5.37% | 13.19K |
$3.69 | $48,624.16 | 258.82K |
Jun 24
| |||
Form 4
| +68.67% | 100K |
—
|
—
| 245.63K |
May 9
| |||
Form 4
| +8.17% | 11K |
$4.26 | $46,864.26 | 145.63K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +2.14% | 2.8K |
$18.75 | $52,425.00 | 133.43K |
Aug 26
| |||
Form 4
| +10.98% | 12.93K |
$10.53 | $136,078.35 | 130.64K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +3.26% | 3.67K |
$4.26 | $15,625.68 | 116.28K |
Jan 21
| |||
Form 4
| +14.98% | 14.67K |
$4.26 | $62,502.72 | 112.61K |
Dec 22
| |||
Form 4
| +17.62% | 14.67K |
$4.26 | $62,498.46 | 97.94K |
Sep 2
| |||
Form 4/A
| +36.05% | 18.34K |
$4.26 | $78,124.14 | 69.21K |
May 21
| |||
Form 4
| +20.32% | 14.06K |
$14.22 | $200,004.30 | 83.27K |
May 27
| |||
Form 4
| +36.04% | 18.33K |
$4.26 | $78,085.80 | 69.2K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +794.48% | 44.01K |
$4.26 | $187,499.64 | 49.55K |
Nov 15
| |||
Form 4
|
∞
| 5.54K |
$18.70 | $103,598.00 | 5.54K |
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pharmasset Inc No price found
VP, Clinical Development & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||